Is CLX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for CLX. It does not provide personalized investment advice.

CLX (Clorox) Stock Analysis - Financials

Clorox (CLX) is a publicly traded Consumer Defensive sector company. As of July 5, 2026, CLX trades at $97.26 with a market cap of $11.76B and a P/E ratio of 15.84. CLX moved +1.22% today. Year to date, CLX is -3.52%; over the trailing twelve months it is -21.98%. Its 52-week range spans $84.70 to $171.37. Analyst consensus is neutral with an average price target of $98.77. Rallies surfaces CLX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are CLX's key financials?

CLX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLX recently traded at $97.26. Market cap is $11.76B. P/E ratio is 15.84. Revenue is $6.76B.

CLX Key Metrics

Key financial metrics for CLX
Metric	Value
Price	$97.26
Market Cap	$11.76B
P/E Ratio	15.84
EPS	$6.14
Dividend Yield	1.24%
52-Week High	$171.37
52-Week Low	$84.70
Volume	0
Avg Volume	0
Revenue (TTM)	$6.76B
Net Income	$770.00M
Gross Margin	44.19%

CLX Analyst Consensus

14 analysts cover CLX: 0 strong buy, 1 buy, 9 hold, 4 sell, 0 strong sell. Consensus rating is neutral. Average price target: $98.77.

Common questions about CLX

What are CLX's key financials?: CLX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CLX recently traded at $97.26. Market cap is $11.76B. P/E ratio is 15.84. Revenue is $6.76B.
Is CLX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for CLX. It does not provide personalized investment advice.